Long-term safety of esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: SUSTAIN-2 phase 3 study
2019
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
17
Citations
NaN
KQI